These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 9772923)

  • 1. Aspergillus nidulans infection in chronic granulomatous disease.
    Segal BH; DeCarlo ES; Kwon-Chung KJ; Malech HL; Gallin JI; Holland SM
    Medicine (Baltimore); 1998 Sep; 77(5):345-54. PubMed ID: 9772923
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Osteomyelitis due to Aspergillus spp. in patients with chronic granulomatous disease: comparison of Aspergillus nidulans and Aspergillus fumigatus.
    Dotis J; Roilides E
    Int J Infect Dis; 2004 Mar; 8(2):103-10. PubMed ID: 14732328
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aspergillus nidulans infection in a patient with chronic granulomatous disease.
    Kim M; Shin JH; Suh SP; Ryang DW; Park CS; Kim C; Kook H; Kim J
    J Korean Med Sci; 1997 Jun; 12(3):244-8. PubMed ID: 9250922
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Virulence of catalase-deficient aspergillus nidulans in p47(phox)-/- mice. Implications for fungal pathogenicity and host defense in chronic granulomatous disease.
    Chang YC; Segal BH; Holland SM; Miller GF; Kwon-Chung KJ
    J Clin Invest; 1998 May; 101(9):1843-50. PubMed ID: 9576747
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Osteomyelitis due to Aspergillus species in chronic granulomatous disease: an update of the literature.
    Dotis J; Roilides E
    Mycoses; 2011 Nov; 54(6):e686-96. PubMed ID: 21615532
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detailed characterisation of invasive aspergillosis in a murine model of X-linked chronic granulomatous disease shows new insights in infections caused by
    King J; Dambuza IM; Reid DM; Yuecel R; Brown GD; Warris A
    Front Cell Infect Microbiol; 2023; 13():1241770. PubMed ID: 37724291
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exogenous Stimulation of Type I Interferon Protects Mice with Chronic Granulomatous Disease from Aspergillosis through Early Recruitment of Host-Protective Neutrophils into the Lung.
    Seyedmousavi S; Davis MJ; Sugui JA; Pinkhasov T; Moyer S; Salazar AM; Chang YC; Kwon-Chung KJ
    mBio; 2018 Mar; 9(2):. PubMed ID: 29588403
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chloroquine modulates the fungal immune response in phagocytic cells from patients with chronic granulomatous disease.
    Henriet SS; Jans J; Simonetti E; Kwon-Chung KJ; Rijs AJ; Hermans PW; Holland SM; de Jonge MI; Warris A
    J Infect Dis; 2013 Jun; 207(12):1932-9. PubMed ID: 23482646
    [TBL] [Abstract][Full Text] [Related]  

  • 9. First case of extensive spinal cord infection with Aspergillus nidulans in a child with chronic granulomatous disease.
    Bukhari E; Alrabiaah A
    J Infect Dev Ctries; 2009 May; 3(4):321-3. PubMed ID: 19759498
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Restoration of anti-Aspergillus defense by neutrophil extracellular traps in human chronic granulomatous disease after gene therapy is calprotectin-dependent.
    Bianchi M; Niemiec MJ; Siler U; Urban CF; Reichenbach J
    J Allergy Clin Immunol; 2011 May; 127(5):1243-52.e7. PubMed ID: 21376380
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Femoral osteomyelitis due to Aspergillus nidulans in a patient with chronic granulomatous disease.
    Dotis J; Panagopoulou P; Filioti J; Winn R; Toptsis C; Panteliadis C; Roilides E
    Infection; 2003 Mar; 31(2):121-4. PubMed ID: 12682820
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Decreased Cell Wall Galactosaminogalactan in Aspergillus nidulans Mediates Dysregulated Inflammation in the Chronic Granulomatous Disease Host.
    Henriet SS; van de Sande WW; Lee MJ; Simonetti E; Momany M; Verweij PE; Rijs AJ; Ferwerda G; Sheppard DC; de Jonge MI; Warris A
    J Interferon Cytokine Res; 2016 Aug; 36(8):488-98. PubMed ID: 27142572
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functional Characterization of Clinical Isolates of the Opportunistic Fungal Pathogen Aspergillus nidulans.
    Bastos RW; Valero C; Silva LP; Schoen T; Drott M; Brauer V; Silva-Rocha R; Lind A; Steenwyk JL; Rokas A; Rodrigues F; Resendiz-Sharpe A; Lagrou K; Marcet-Houben M; Gabaldón T; McDonnell E; Reid I; Tsang A; Oakley BR; Loures FV; Almeida F; Huttenlocher A; Keller NP; Ries LNA; Goldman GH
    mSphere; 2020 Apr; 5(2):. PubMed ID: 32269156
    [No Abstract]   [Full Text] [Related]  

  • 14. Efficacy of Olorofim (F901318) against
    Seyedmousavi S; Chang YC; Law D; Birch M; Rex JH; Kwon-Chung KJ
    Antimicrob Agents Chemother; 2019 Jun; 63(6):. PubMed ID: 30885903
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human leukocytes kill Aspergillus nidulans by reactive oxygen species-independent mechanisms.
    Henriet SS; Hermans PW; Verweij PE; Simonetti E; Holland SM; Sugui JA; Kwon-Chung KJ; Warris A
    Infect Immun; 2011 Feb; 79(2):767-73. PubMed ID: 21078850
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aspergillus nidulans and chronic granulomatous disease: a unique host-pathogen interaction.
    Henriet SS; Verweij PE; Warris A
    J Infect Dis; 2012 Oct; 206(7):1128-37. PubMed ID: 22829648
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lessons about the pathogenesis and management of aspergillosis from studies in chronic granulomatous disease.
    Gallin JI; Zarember K
    Trans Am Clin Climatol Assoc; 2007; 118():175-85. PubMed ID: 18528501
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Successful treatment with voriconazole of invasive aspergillosis in chronic granulomatous disease.
    van 't Hek LG; Verweij PE; Weemaes CM; van Dalen R; Yntema JB; Meis JF
    Am J Respir Crit Care Med; 1998 May; 157(5 Pt 1):1694-6. PubMed ID: 9603157
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Invasive mold infections in chronic granulomatous disease: a 25-year retrospective survey.
    Blumental S; Mouy R; Mahlaoui N; Bougnoux ME; Debré M; Beauté J; Lortholary O; Blanche S; Fischer A
    Clin Infect Dis; 2011 Dec; 53(12):e159-69. PubMed ID: 22080130
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential Kinetics of Aspergillus nidulans and Aspergillus fumigatus Phagocytosis.
    Gresnigt MS; Becker KL; Leenders F; Alonso MF; Wang X; Meis JF; Bain JM; Erwig LP; van de Veerdonk FL
    J Innate Immun; 2018; 10(2):145-160. PubMed ID: 29248928
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.